How effective is chemotherapy for Waldenstrom macroglobulinaemia?

Waldenstrom macroglobulinaemia is a lymphoplasmacytic blood cancer that can produce an abnormal antibody called an IgM protein. Treatment may reduce the cells making this protein and ease problems such as fatigue, enlarged lymph nodes, bleeding, vision changes or nerve symptoms. Some people without troublesome symptoms are monitored rather than treated immediately. When treatment is needed, chemotherapy may be combined with targeted or antibody treatment. Blood tests, symptom review and examination help the team see whether the IgM level and the effects of the disease are changing. A laboratory improvement and feeling better do not always occur at the same pace.

Ask whether your disease needs treatment now and what result the team hopes to achieve. Share details of numbness, headaches, dizziness, blurred vision, unusual bleeding, infections and breathlessness. Your team may review blood counts, kidney function and the IgM level before each treatment decision. Discuss vaccination, infection precautions, other medicines and fertility concerns before therapy begins. Keep a list of new symptoms and bring it to appointments; this helps distinguish disease effects from medicine side effects.

Seek urgent medical advice for new or worsening blurred vision, severe headache, confusion, fainting, chest pain, breathlessness, uncontrolled bleeding or a high temperature during treatment. These symptoms can signal infection, bleeding or very thick blood and need rapid assessment. Call emergency services for collapse, severe breathing difficulty or sudden loss of vision.

What features of my Waldenstrom macroglobulinaemia make treatment necessary? Is chemotherapy being combined with another medicine? Which blood and symptom changes will show a response? Which symptoms should trigger an urgent call?